That's why I believe the stock of BrightSpring has a lot of potential for growth!

BrightSpring went public two years ago and offers healthcare services for individuals with complex and chronic conditions, whose treatment is typically costly. There are several growth drivers. For instance, the acquisition of 127 home care locations from Amedisys is pending. This acquisition is expected to positively impact the financials this year, as it will have an immediately value-enhancing effect. BrightSpring has an excellently positioned specialty pharmacy (Onco360), which has optimized its internal processes over the last 10 years...